Comparison of COVID-19-related symptoms and outcome in 582 children from 21 European countries (78% reported from tertiary and quaternary institutions)8 and 113 children on immunosuppression for kidney disease in our study.
| 582 paediatric cases | 113 paediatric cases on immunosuppressive therapy for kidney disease | |
| Admitted to hospital | 62% | 60% |
| Asymptomatic SARS-CoV-2 infection | 16% | 19% |
| Fever | 65% | 65% |
| URT symptoms | 54% | 52% |
| GI symptoms | 22% | 15% |
| Supplemental oxygen/high-flow nasal cannula oxygen | 13% | 17% |
| CPAP/BiPAP | 5% | 1% |
| Mechanical ventilation | 4% | 4% |
| Mortality | 1% | 4% (0% Europe and USA) |
BiPAP, bi-level positive airway pressure; CPAP, continuous positive airway pressure; GI, gastrointestinal; URT, upper respiratory tract.